demonstrated that in neuronal cells that tirzepatide activates Akt/CREB/BDNF pathway and the downstream signaling cascade counteracting hyperglycemia and insulin resistance-related damage at the neuronal level (51). The gene discussed is AKT1; the disease is Insulin resistance.